Hennion & Walsh Asset Management, Inc. Enanta Pharmaceuticals Inc Transaction History

Hennion & Walsh Asset Management, Inc.

$1.84 Billion
Q1 2024

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 13,689 shares of ENTA stock, worth $177,546. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,689

Previous 15,751 13.09%

Holding current value

$177,546

Previous $148,000 61.49%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$10.08 - $17.46 $20,784 - $36,002	-2,062 Reduced 13.09%	13,689 $239,000
Q4 2023 Jan 10, 2024	SELL	$8.18 - $10.78 $100,474 - $132,410	-12,283 Reduced 43.81%	15,751 $148,000
Q3 2023 Oct 27, 2023	SELL	$11.09 - $22.13 $26,394 - $52,669	-2,380 Reduced 7.83%	28,034 $313,000
Q2 2023 Aug 09, 2023	SELL	$20.68 - $39.85 $3,412 - $6,575	-165 Reduced 0.54%	30,414 $651,000
Q1 2023 Apr 20, 2023	SELL	$38.82 - $54.59 $29,115 - $40,942	-750 Reduced 2.39%	30,579 $1.24 Million

Q4 2022 Jan 12, 2023	SELL	$40.77 - $53.73 $1.59 Million - $2.1 Million	-38,995 Reduced 55.45%	31,329 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $342,665 - $505,731	-7,096 Reduced 9.17%	70,324 $3.65 Million
Q2 2022 Jul 19, 2022	SELL	$38.13 - $76.93 $1.03 Million - $2.08 Million	-27,074 Reduced 25.91%	77,420 $3.66 Million
Q1 2022 Apr 26, 2022	BUY	$56.06 - $74.11 $136,225 - $180,087	2,430 Added 2.38%	104,494 $7.44 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $1.09 Million - $1.77 Million	-18,176 Reduced 15.12%	102,064 $7.63 Million
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $169,822 - $242,811	-4,140 Reduced 3.33%	120,240 $6.83 Million
Q2 2021 Aug 13, 2021	BUY	$43.76 - $53.11 $456,854 - $554,468	10,440 Added 9.16%	124,380 $5.47 Million
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $4.75 Million - $6.26 Million	113,940 New	113,940 $5.62 Million

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.7M

Call Options Held

9.4K

Put Options Held

3.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Enanta Pharmaceuticals Inc Transaction History